Multi-Omics Mendelian Randomization Identifies Therapeutic Targets for Sjögren’s Disease with Clinical and Bayesian Validation
Journal of Inflammation Research · 2025-11 · Volume 18 · 16685-16698
DOI: 10.2147/jir.s543644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2025-11. Verfasst von Jiale He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China.
Zitieren
APA
He, J., Li, K., Guo, Z., Zhou, X., & Tang, X. (2025). Multi-Omics Mendelian Randomization Identifies Therapeutic Targets for Sjögren’s Disease with Clinical and Bayesian Validation. Journal of Inflammation Research, Volume 18, 16685-16698. https://doi.org/10.2147/jir.s543644
Vancouver
He J, Li K, Guo Z, Zhou X, Tang X. Multi-Omics Mendelian Randomization Identifies Therapeutic Targets for Sjögren’s Disease with Clinical and Bayesian Validation. Journal of Inflammation Research. 2025;Volume 18:16685-16698. doi:10.2147/jir.s543644
BibTeX
@article{He2025,
author = {He, Jiale and Li, Kesong and Guo, Zilin and Zhou, Xinyao and Tang, Xiaopo},
title = {Multi-Omics Mendelian Randomization Identifies Therapeutic Targets for Sjögren’s Disease with Clinical and Bayesian Validation},
journal = {Journal of Inflammation Research},
year = {2025},
volume = {Volume 18},
pages = {16685--16698},
doi = {10.2147/jir.s543644}
}
EUVIMED